CureVac NV (CVAC)
3.89
+0.12
(+3.18%)
USD |
NASDAQ |
May 31, 16:00
3.88
-0.01
(-0.26%)
Pre-Market: 20:00
CureVac Accounts Receivable (Quarterly): 15.81M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 15.81M |
December 31, 2023 | 15.84M |
September 30, 2023 | 11.09M |
June 30, 2023 | 7.002M |
March 31, 2023 | 3.685M |
December 31, 2022 | 6.751M |
September 30, 2022 | 6.064M |
June 30, 2022 | 13.94M |
Date | Value |
---|---|
March 31, 2022 | 31.28M |
December 31, 2021 | 20.95M |
September 30, 2021 | 2.844M |
June 30, 2021 | 3.085M |
December 31, 2020 | 1.247M |
September 30, 2020 | 0.00 |
March 31, 2020 | 2.658M |
December 31, 2019 | 17.58M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2020
31.28M
Maximum
Mar 2022
9.988M
Average
6.876M
Median
Accounts Receivable (Quarterly) Benchmarks
BioNTech SE | 1.771B |
Affimed NV | 5.888M |
InflaRx NV | 0.0381M |
MorphoSys AG | 35.48M |
Immatics NV | 1.923M |